Gossamer Bio Inc (GOSS)
0.74
-0.03
(-4.06%)
USD |
NASDAQ |
May 03, 16:00
0.7351
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Price to Book Value: 2.667 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.667 |
| May 02, 2024 | 2.780 |
| May 01, 2024 | 2.550 |
| April 30, 2024 | 2.559 |
| April 29, 2024 | 2.510 |
| April 26, 2024 | 2.408 |
| April 25, 2024 | 2.415 |
| April 24, 2024 | 2.553 |
| April 23, 2024 | 2.658 |
| April 22, 2024 | 2.678 |
| April 19, 2024 | 2.825 |
| April 18, 2024 | 2.905 |
| April 17, 2024 | 2.955 |
| April 16, 2024 | 2.958 |
| April 15, 2024 | 3.084 |
| April 12, 2024 | 3.217 |
| April 11, 2024 | 3.477 |
| April 10, 2024 | 3.593 |
| April 09, 2024 | 3.594 |
| April 08, 2024 | 3.881 |
| April 05, 2024 | 3.702 |
| April 04, 2024 | 3.845 |
| April 03, 2024 | 3.989 |
| April 02, 2024 | 4.133 |
| April 01, 2024 | 4.564 |
| Date | Value |
|---|---|
| March 28, 2024 | 4.241 |
| March 27, 2024 | 4.205 |
| March 26, 2024 | 4.420 |
| March 25, 2024 | 4.708 |
| March 22, 2024 | 4.852 |
| March 21, 2024 | 4.744 |
| March 20, 2024 | 4.852 |
| March 19, 2024 | 4.996 |
| March 18, 2024 | 4.960 |
| March 15, 2024 | 5.247 |
| March 14, 2024 | 5.031 |
| March 13, 2024 | 5.139 |
| March 12, 2024 | 5.031 |
| March 11, 2024 | 4.816 |
| March 08, 2024 | 4.960 |
| March 07, 2024 | 4.996 |
| March 06, 2024 | 5.427 |
| March 05, 2024 | 5.211 |
| March 04, 2024 | 5.211 |
| March 01, 2024 | 4.960 |
| February 29, 2024 | 5.067 |
| February 28, 2024 | 4.888 |
| February 27, 2024 | 4.420 |
| February 26, 2024 | 4.561 |
| February 23, 2024 | 4.668 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.031
Minimum
Oct 24 2023
25.31
Maximum
Apr 08 2022
5.366
Average
2.843
Median
Apr 23 2020
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 19.18 |
| TG Therapeutics Inc | 1.641 |
| Replimune Group Inc | 1.012 |
| 89bio Inc | 1.637 |
| Moderna Inc | 3.738 |
Price to Book Value Related Metrics
| Price | 0.74 |
| Earnings Yield | -179.7% |
| Market Cap | 167.40M |